Back to Search
Start Over
Neoadjuvant savolitinib targeted therapy for stage IIIB-N3 lung adenocarcinoma harboring mesenchymal-epithelial transition exon 14 skipping mutation: a case report and literature review.
- Source :
- Anti-Cancer Drugs; Jun2024, Vol. 35 Issue 5, p445-449, 5p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 09594973
- Volume :
- 35
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Anti-Cancer Drugs
- Publication Type :
- Academic Journal
- Accession number :
- 176894635
- Full Text :
- https://doi.org/10.1097/CAD.0000000000001581